PUBLICATION:
Int J Cancer. 2013 Aug 15;133(4):929-36. doi: 10.1002/ijc.28082. Epub 2013 Mar 4.
AUTHORS:
Drukker C.A., Bueno-de-Mesquita J.M., Retèl V.P., van Harten W.H., van Tinteren H., Wesseling J., Roumen R.M., Knauer M., van’t Veer L.J., Sonke G.S., Rutgers E.J., van de Vijver M.J., Linn S.C.
SUMMARY:
A prospective community based observational study, the 5-year DRFI probabilities confirmed the additional prognostic value of the 70-gene signature to clinicopathological risk estimations such as AOL.
